In several lines of prostate cancer, including PC-3, LNCaP, and DU-145, it has been demonstrated that cryptophycin 52 is capable of activating the phosphorylation of BCL-xL and BCL-2 [194]. This evidence concerns the gene BCL2 and prostate carcinoma.